Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Total cardiovascular risk management.

Eberhard Ritz1

  • 1Division of Nephrology, Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany. prof.e.ritz@t-online.de

The American Journal of Cardiology
|September 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kidney & blood pressure research·2018
Same author

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Clinical and experimental nephrology·2017
Same author

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Clinical kidney journal·2016
Same author

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

BMC nephrology·2016
Same author

Bariatric surgery and the kidney-much benefit, but also potential harm.

Clinical kidney journal·2016
Same author

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Journal of hypertension·2016
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Effective hypertension management requires addressing clustered cardiovascular risk factors. Multifactorial interventions, targeting blood pressure and other risks, are crucial for improving long-term cardiovascular health and reducing morbidity.

Area of Science:

  • Cardiology
  • Public Health
  • Endocrinology

Background:

  • Hypertension frequently coexists with other cardiovascular risk factors like insulin resistance, obesity, and dyslipidemia.
  • Inadequate blood pressure control (<25% of patients) highlights a significant gap in managing hypertension.
  • Global cardiovascular risk is elevated by risk factors, target organ damage, comorbidities, and metabolic syndrome.

Purpose of the Study:

  • To emphasize the inadequacy of isolated hypertension treatment.
  • To advocate for comprehensive cardiovascular risk assessment and management.
  • To highlight the benefits of multifactorial interventions over single-factor approaches.

Main Methods:

  • Review of current understanding of cardiovascular risk factors and hypertension management.

Related Experiment Videos

  • Analysis of the impact of clustered risk factors on cardiovascular morbidity and mortality.
  • Evaluation of international treatment guidelines incorporating global cardiovascular risk.

    • Main Results:

    • Multifactorial interventions are highly effective in reducing cardiovascular risk and events, particularly in patients with type 2 diabetes mellitus.
    • Small reductions across multiple risk factors can be more beneficial than large reductions in a single factor.
    • Individuals with borderline blood pressure and glucose levels face increased cardiovascular disease risk.

    Conclusions:

    • Isolated treatment of hypertension is insufficient for improving long-term cardiovascular health.
    • Active identification and treatment of associated risk factors and target organ damage are essential.
    • Adopting a global cardiovascular risk management approach is critical for better patient outcomes.